Shanghai Fosun Pharmaceutical (Group) Co Ltd (SFOSF)
1.55
+0.02
(+1.17%)
USD |
OTCM |
Apr 29, 16:00
Shanghai Fosun Pharmaceutical Price to Book Value: 0.6427 for April 29, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 29, 2024 | 0.6427 |
| April 26, 2024 | 0.6353 |
| April 25, 2024 | 0.6353 |
| April 24, 2024 | 0.6353 |
| April 23, 2024 | 0.6353 |
| April 22, 2024 | 0.6353 |
| April 19, 2024 | 0.6353 |
| April 18, 2024 | 0.6353 |
| April 17, 2024 | 0.6353 |
| April 16, 2024 | 0.6353 |
| April 15, 2024 | 0.6353 |
| April 12, 2024 | 0.6353 |
| April 11, 2024 | 0.6353 |
| April 10, 2024 | 0.6353 |
| April 09, 2024 | 0.6282 |
| April 08, 2024 | 0.6282 |
| April 05, 2024 | 0.6282 |
| April 04, 2024 | 0.6541 |
| April 03, 2024 | 0.6541 |
| April 02, 2024 | 0.6635 |
| April 01, 2024 | 0.6956 |
| March 28, 2024 | 0.6935 |
| March 27, 2024 | 0.6925 |
| March 26, 2024 | 0.708 |
| March 25, 2024 | 0.6904 |
| Date | Value |
|---|---|
| March 22, 2024 | 0.7381 |
| March 21, 2024 | 0.7257 |
| March 20, 2024 | 0.7257 |
| March 19, 2024 | 0.7682 |
| March 18, 2024 | 0.7837 |
| March 15, 2024 | 0.7847 |
| March 14, 2024 | 0.7868 |
| March 13, 2024 | 0.7868 |
| March 12, 2024 | 0.7868 |
| March 11, 2024 | 0.7868 |
| March 08, 2024 | 0.7588 |
| March 07, 2024 | 0.7599 |
| March 06, 2024 | 0.7785 |
| March 05, 2024 | 0.7599 |
| March 04, 2024 | 0.7516 |
| March 01, 2024 | 0.7682 |
| February 29, 2024 | 0.7339 |
| February 28, 2024 | 0.7246 |
| February 27, 2024 | 0.7474 |
| February 26, 2024 | 0.7858 |
| February 23, 2024 | 0.7464 |
| February 22, 2024 | 0.7443 |
| February 21, 2024 | 0.7371 |
| February 20, 2024 | 0.7246 |
| February 16, 2024 | 0.7194 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.6282
Minimum
Apr 05 2024
4.280
Maximum
Aug 04 2021
1.749
Average
1.729
Median
Jun 06 2022
Price to Book Value Benchmarks
| Sinovac Biotech Ltd | -- |
| CASI Pharmaceuticals Inc | 1.298 |
| Zai Lab Ltd | 2.051 |
| I-MAB | 0.5960 |
| Gracell Biotechnologies Inc (DELISTED) | -- |
Price to Book Value Related Metrics
| PE Ratio | 12.31 |
| PS Ratio | 0.7151 |
| Price | 1.55 |
| Earnings Yield | 8.12% |
| Market Cap | 4.142B |
| Operating PE Ratio | 18.50 |
| Normalized PE Ratio | 10.06 |